• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury.晚期糖基化终末产物受体是急性肺损伤中I型细胞损伤的标志物。
Am J Respir Crit Care Med. 2006 May 1;173(9):1008-15. doi: 10.1164/rccm.200509-1477OC. Epub 2006 Feb 2.
2
Neutrophil-derived S100A12 in acute lung injury and respiratory distress syndrome.急性肺损伤和呼吸窘迫综合征中中性粒细胞衍生的S100A12
Crit Care Med. 2007 May;35(5):1369-75. doi: 10.1097/01.CCM.0000262386.32287.29.
3
Receptor for advanced glycation end-products (RAGE) is an indicator of direct lung injury in models of experimental lung injury.晚期糖基化终末产物受体(RAGE)是实验性肺损伤模型中直接肺损伤的一个指标。
Am J Physiol Lung Cell Mol Physiol. 2009 Jul;297(1):L1-5. doi: 10.1152/ajplung.90546.2008. Epub 2009 May 1.
4
Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1beta-dependent mechanism.急性肺损伤患者的肺水肿液通过白细胞介素-1β依赖机制增强体外肺泡上皮修复。
Am J Respir Crit Care Med. 2001 May;163(6):1384-8. doi: 10.1164/ajrccm.163.6.2006131.
5
Elevated plasma and alveolar levels of soluble receptor for advanced glycation endproducts are associated with severity of lung dysfunction in ARDS patients.血浆和肺泡中可溶性晚期糖基化终产物受体水平升高与 ARDS 患者肺功能障碍的严重程度相关。
Tohoku J Exp Med. 2010 Oct;222(2):105-12. doi: 10.1620/tjem.222.105.
6
Soluble Receptor for Advanced Glycation End-Products Predicts Impaired Alveolar Fluid Clearance in Acute Respiratory Distress Syndrome.可溶性晚期糖基化终产物受体预测急性呼吸窘迫综合征肺泡液体清除功能受损。
Am J Respir Crit Care Med. 2015 Jul 15;192(2):191-9. doi: 10.1164/rccm.201501-0020OC.
7
Role of Receptor for Advanced Glycation End Products in Regulating Lung Fluid Balance in Lipopolysaccharide-induced Acute Lung Injury and Infection-Related Acute Respiratory Distress Syndrome.晚期糖基化终产物受体在脂多糖诱导的急性肺损伤和感染相关急性呼吸窘迫综合征中调节肺液平衡的作用。
Shock. 2018 Oct;50(4):472-482. doi: 10.1097/SHK.0000000000001032.
8
Hepatocyte growth factor and keratinocyte growth factor in the pulmonary edema fluid of patients with acute lung injury. Biologic and clinical significance.急性肺损伤患者肺水肿液中的肝细胞生长因子和角质形成细胞生长因子。生物学及临床意义。
Am J Respir Crit Care Med. 1998 Aug;158(2):386-94. doi: 10.1164/ajrccm.158.2.9711111.
9
VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema.肺泡腔中的血管内皮生长因子水平无法区分急性呼吸窘迫综合征和静水压性肺水肿。
Eur Respir J. 2005 Jul;26(1):101-5. doi: 10.1183/09031936.05.00106604.
10
Role of soluble receptor for advanced glycation end products on endotoxin-induced lung injury.可溶性晚期糖基化终末产物受体在内毒素诱导的肺损伤中的作用
Am J Respir Crit Care Med. 2008 Aug 15;178(4):356-62. doi: 10.1164/rccm.200707-1069OC. Epub 2008 Jun 5.

引用本文的文献

1
Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS.靶向全程序性细胞死亡:急性肺损伤/急性呼吸窘迫综合征的一种有前景的治疗策略。
Apoptosis. 2025 Sep 4. doi: 10.1007/s10495-025-02168-z.
2
A mouse model of E-cigarette or vaping product use-associated lung injury (EVALI) induced by nose-only exposure to aerosolized vitamin E acetate and associated macrophage dysfunction.通过仅经鼻暴露于雾化维生素E醋酸酯诱导的电子烟或雾化产品使用相关肺损伤(EVALI)小鼠模型及相关巨噬细胞功能障碍。
Respir Res. 2025 Aug 31;26(1):263. doi: 10.1186/s12931-025-03343-1.
3
Research Priorities for Noninvasive Sampling of the Lower Respiratory Tract during Acute Respiratory Failure: An Official American Thoracic Society Workshop Report.急性呼吸衰竭期间下呼吸道无创采样的研究重点:美国胸科学会官方研讨会报告
Ann Am Thorac Soc. 2025 Aug;22(8):1101-1114. doi: 10.1513/AnnalsATS.202505-543ST.
4
Long-term Reprogramming and Altered Ontogeny of Classical Monocytes Mediates Enhanced Lung Injury in Sepsis Survivor Mice.经典单核细胞的长期重编程和个体发生改变介导脓毒症存活小鼠的肺损伤加重
bioRxiv. 2025 May 21:2025.05.16.654442. doi: 10.1101/2025.05.16.654442.
5
Development of an acute lung injury model for drug testing.用于药物测试的急性肺损伤模型的建立。
Sci Rep. 2025 May 21;15(1):17703. doi: 10.1038/s41598-025-02078-9.
6
Correlations between primary tumour location, biomarkers of inflammation and lung injury, and postoperative pulmonary complications in patients underwent laparoscopic colorectomy: a propensity score matched analysis of 300 patients.接受腹腔镜结直肠癌切除术患者的原发肿瘤位置、炎症和肺损伤生物标志物与术后肺部并发症之间的相关性:300例患者的倾向评分匹配分析
Front Immunol. 2025 Jan 30;16:1546167. doi: 10.3389/fimmu.2025.1546167. eCollection 2025.
7
Advancements in omics technologies: Molecular mechanisms of acute lung injury and acute respiratory distress syndrome (Review).组学技术进展:急性肺损伤和急性呼吸窘迫综合征的分子机制(综述)
Int J Mol Med. 2025 Mar;55(3). doi: 10.3892/ijmm.2024.5479. Epub 2025 Jan 3.
8
Pathological role of RAGE underlying progression of various diseases: its potential as biomarker and therapeutic target.晚期糖基化终末产物受体(RAGE)在多种疾病进展中的病理作用:其作为生物标志物和治疗靶点的潜力
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):3467-3487. doi: 10.1007/s00210-024-03595-6. Epub 2024 Nov 26.
9
The predictive capacity of biomarkers for clinical pulmonary oedema in patients with severe falciparum malaria is low: a prospective observational study.生物标志物对严重恶性疟患者临床肺水肿的预测能力较低:一项前瞻性观察研究。
Malar J. 2024 Oct 24;23(1):320. doi: 10.1186/s12936-024-05142-3.
10
Association of Acute Systemic Inflammation with Patient-Centric Postoperative Pulmonary Complications After Elective Cardiac Surgery.择期心脏手术后急性全身炎症与以患者为中心的术后肺部并发症的关联
Anesth Analg. 2025 Apr 1;140(4):947-956. doi: 10.1213/ANE.0000000000007122. Epub 2024 Aug 8.

本文引用的文献

1
Clinical practice. Acute pulmonary edema.临床实践。急性肺水肿。
N Engl J Med. 2005 Dec 29;353(26):2788-96. doi: 10.1056/NEJMcp052699.
2
Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury.前B细胞集落增强因子作为急性肺损伤潜在的新型生物标志物。
Am J Respir Crit Care Med. 2005 Feb 15;171(4):361-70. doi: 10.1164/rccm.200404-563OC. Epub 2004 Dec 3.
3
RAGE (receptor for advanced glycation end products): a central player in the inflammatory response.晚期糖基化终产物受体(RAGE):炎症反应的核心参与者。
Microbes Infect. 2004 Nov;6(13):1219-25. doi: 10.1016/j.micinf.2004.08.004.
4
Decreased expression of aquaporin-5 in bleomycin-induced lung fibrosis in the mouse.水通道蛋白5在博来霉素诱导的小鼠肺纤维化中表达降低。
Pathol Int. 2004 Oct;54(10):774-80. doi: 10.1111/j.1440-1827.2004.01754.x.
5
The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair.使用肺泡I型上皮细胞选择性标志物来研究肺损伤与修复。
Eur Respir J. 2004 Oct;24(4):664-73. doi: 10.1183/09031936.04.00096003.
6
Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE).小鼠晚期糖基化终末产物可溶性受体(sRAGE)的纯化与鉴定
J Biol Chem. 2004 Nov 26;279(48):50019-24. doi: 10.1074/jbc.M409782200. Epub 2004 Sep 20.
7
Identification of genes differentially expressed in rat alveolar type I cells.大鼠Ⅰ型肺泡细胞中差异表达基因的鉴定
Am J Respir Cell Mol Biol. 2004 Sep;31(3):309-16. doi: 10.1165/rcmb.2003-0423OC. Epub 2004 Jun 17.
8
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response.晚期糖基化终末产物受体(RAGE)调节脓毒症,但不调节适应性免疫反应。
J Clin Invest. 2004 Jun;113(11):1641-50. doi: 10.1172/JCI18704.
9
Receptor for advanced glycation end-products is a marker of type I lung alveolar cells.晚期糖基化终末产物受体是I型肺泡细胞的标志物。
Genes Cells. 2004 Feb;9(2):165-74. doi: 10.1111/j.1356-9597.2004.00712.x.
10
Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond.糖基化、炎症与晚期糖基化终末产物受体:糖尿病及其他疾病大血管并发症的一个框架
Circ Res. 2003 Dec 12;93(12):1159-69. doi: 10.1161/01.RES.0000103862.26506.3D.

晚期糖基化终末产物受体是急性肺损伤中I型细胞损伤的标志物。

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury.

作者信息

Uchida Tokujiro, Shirasawa Madoka, Ware Lorraine B, Kojima Katsuo, Hata Yutaka, Makita Koshi, Mednick Gabe, Matthay Zachary A, Matthay Michael A

机构信息

Department of Anesthesiology, Graduate School of Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan.

出版信息

Am J Respir Crit Care Med. 2006 May 1;173(9):1008-15. doi: 10.1164/rccm.200509-1477OC. Epub 2006 Feb 2.

DOI:10.1164/rccm.200509-1477OC
PMID:16456142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2662912/
Abstract

RATIONALE

Receptor for advanced glycation end-products (RAGE) is one of the alveolar type I cell-associated proteins in the lung.

OBJECTIVES

To test the hypothesis that RAGE is a marker of alveolar epithelial type I cell injury.

METHODS

Rats were instilled intratracheally with 10 mg/kg lipopolysaccharide or hydrochloric acid. RAGE levels were measured in the bronchoalveolar lavage (BAL) and serum in the rats and in the pulmonary edema fluid and plasma from patients with acute lung injury (ALI; n = 22) and hydrostatic pulmonary edema (n = 11).

MAIN RESULTS

In the rat lung injury studies, RAGE was released into the BAL and serum as a single soluble isoform sized approximately 48 kD. The elevated levels of RAGE in the BAL correlated well with the severity of experimentally induced lung injury. In the human studies, the RAGE level in the pulmonary edema fluid was significantly higher than the plasma level (p < 0.0001). The median edema fluid/plasma ratio of RAGE levels was 105 (interquartile range, 55-243). The RAGE levels in the pulmonary edema fluid from patients with ALI were higher than the levels from patients with hydrostatic pulmonary edema (p < 0.05), and the plasma RAGE level in patients with ALI were significantly higher than the healthy volunteers (p < 0.001) or patients with hydrostatic pulmonary edema (p < 0.05).

CONCLUSION

RAGE is a marker of type I alveolar epithelial cell injury based on experimental studies in rats and in patients with ALI.

摘要

原理

晚期糖基化终末产物受体(RAGE)是肺中与I型肺泡细胞相关的蛋白之一。

目的

检验RAGE是I型肺泡上皮细胞损伤标志物这一假说。

方法

给大鼠气管内注入10 mg/kg脂多糖或盐酸。检测大鼠支气管肺泡灌洗(BAL)液和血清以及急性肺损伤(ALI;n = 22)和静水压性肺水肿(n = 11)患者的肺水肿液和血浆中的RAGE水平。

主要结果

在大鼠肺损伤研究中,RAGE以单一大小约为48 kD的可溶性异构体形式释放到BAL液和血清中。BAL液中RAGE水平升高与实验性诱导的肺损伤严重程度密切相关。在人体研究中,肺水肿液中的RAGE水平显著高于血浆水平(p < 0.0001)。RAGE水平的水肿液/血浆中位数比值为105(四分位间距,55 - 243)。ALI患者肺水肿液中的RAGE水平高于静水压性肺水肿患者(p < 0.05),ALI患者的血浆RAGE水平显著高于健康志愿者(p < 0.001)或静水压性肺水肿患者(p < 0.05)。

结论

基于对大鼠和ALI患者的实验研究,RAGE是I型肺泡上皮细胞损伤的标志物。